A population-adjusted indirect treatment comparison of efficacy and safety of aumolertinib vs osimertinib in EGFR-mutated non-small cell lung cancer
- Resource Type
- Source
- Lung Cancer. 178:S36-S37
- Subject
Pulmonary and Respiratory Medicine Cancer Research Oncology - Language
- ISSN
- 0169-5002